113 related articles for article (PubMed ID: 1943730)
1. Clinical utility of red blood cell carbonic anhydrase I and zinc concentrations in patients with thyroid diseases.
Yoshida K; Kiso Y; Watanabe T; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K
Metabolism; 1991 Oct; 40(10):1048-51. PubMed ID: 1943730
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months.
Kiso Y; Yoshida K; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K
J Clin Endocrinol Metab; 1991 Feb; 72(2):515-8. PubMed ID: 1899425
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroid hormone on erythrocyte carbonic anhydrase-I and zinc concentrations in vivo and in vitro: clinical usefulness of carbonic anhydrase-I and zinc concentrations in erythrocytes.
Yoshida K
Tohoku J Exp Med; 1996 Apr; 178(4):345-56. PubMed ID: 8804152
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
Yoshida K
Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte zinc concentration in patients with subacute thyroiditis.
Yoshida K; Kiso Y; Watanabe T; Kaise K; Kaise N; Fukazawa H; Yamamoto M; Sakurada T; Yoshinaga K
J Clin Endocrinol Metab; 1990 Mar; 70(3):788-91. PubMed ID: 2307731
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte zinc in hyperthyroidism: reflection of integrated thyroid hormone levels over the previous few months.
Yoshida K; Kiso Y; Watanabe TK; Kaise K; Kaise N; Itagaki Y; Yamamoto M; Sakurada T; Yoshinaga K
Metabolism; 1990 Feb; 39(2):182-6. PubMed ID: 2299989
[TBL] [Abstract][Full Text] [Related]
7. Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis.
Sayama N; Yoshida K; Mori K; Fukazawa H; Hori H; Nakazato N; Tani J; Nakagawa Y; Ito S
Endocr J; 1998 Dec; 45(6):767-72. PubMed ID: 10395232
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte carbonic anhydrase I concentration in patients receiving thyroxine.
Yoshida K; Kiso Y; Kurihara H; Kaise K; Kaise N; Fukazawa H; Mori K; Kikuchi K; Yoshinaga K
Endocrinol Jpn; 1991 Aug; 38(4):363-7. PubMed ID: 1802677
[TBL] [Abstract][Full Text] [Related]
9. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
10. Investigation of red blood cell carbonic anhydrase, glucose 6-phosphate dehydrogenase, hexokinase enzyme activities, and zinc concentration in patients with hyperthyroid diseases.
Odçikin E; Ozdemir H; Ciftçi M; Capoğlu I
Endocr Res; 2002; 28(1-2):61-8. PubMed ID: 12108790
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
12. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
[TBL] [Abstract][Full Text] [Related]
13. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
14. Effects of thyroid hormone on carbonic anhydrase I levels in human erythroid (YN-1) cells.
Kikuchi K; Yoshida K; Endo K; Aizawa Y; Fukazawa H; Mori K; Abe K
J Clin Endocrinol Metab; 1994 Jul; 79(1):71-5. PubMed ID: 8027257
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte zinc concentration as an indicator to distinguish painless thyroiditis-associated transient hypothyroidism from permanent hypothyroidism.
Kuriyama C; Mori K; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S; Inoue M; Ohta M; Yoshida K
Endocr J; 2011; 58(1):59-63. PubMed ID: 20962436
[TBL] [Abstract][Full Text] [Related]
16. An elevation of stem cell factor in patients with hyperthyroid Graves' disease.
Yamada T; Sato A; Aizawa T; Ootsuka H; Miyahara Y; Sakai H; Terao A; Onuma S; Ito Y; Kanamori A; Nakamura Y; Tejima E
Thyroid; 1998 Jun; 8(6):499-504. PubMed ID: 9669287
[TBL] [Abstract][Full Text] [Related]
17. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
[TBL] [Abstract][Full Text] [Related]
18. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
Golden MP; Kaplan SA; Lippe BM; Lee WN
Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
